Cardiac Resynchronization in the Elderly



Status:Recruiting
Conditions:Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:75 - Any
Updated:3/6/2019
Start Date:March 21, 2017
End Date:February 2020
Contact:Samir Saba, MD
Email:sabas@upmc.edu
Phone:412-647-2762

Use our guide to learn which trials are right for you!

Cardiac Resynchronization in the Elderly: Piloting Pacemaker vs. Defibrillator Therapy (Randomized Trial)

This pilot will enroll 50 HF patients (age ≥ 75 years) undergoing CRT device implantation at
the hospitals of the University of Pittsburgh Medical Center, Duke University, Ohio State
University, and the VA Pittsburgh Healthcare System. Patients will be randomized to CRT-P
versus CRT-D and followed until study end. Rates of patient screening, enrollment,
randomization, and retention as well as cost of care will be examined. The results of this
pilot study will inform the design of a large pivotal non-inferiority trial and will be
necessary for its success. Patients who refuse participation in the randomized pilot trial
will be asked to enroll in a prospective observational cohort. Characteristics of patients
who choose CRT-P vs. CRT-D will be compared and patients' level of satisfaction with their
device decision will be measured.

The goal of this study is to pilot test a randomized, controlled, non-inferiority trial
comparing the survival and quality of life (QOL) of older patients receiving cardiac
resynchronization therapy (CRT) pacemaker (CRT-P) versus defibrillator (CRT-D) therapy. This
pilot will enroll 50 HF patients (age ≥ 75 years) undergoing CRT device implantation at the
hospitals of the University of Pittsburgh Medical Center, Duke University, Ohio State
University, and the VA Pittsburgh Healthcare System. Patients will be randomized to CRT-P
versus CRT-D and followed until study end. Rates of patient screening, enrollment,
randomization, and retention as well as cost of care will be examined. The results of this
pilot study will inform the design of a large pivotal non-inferiority trial and will be
necessary for its success. Patients who refuse participation in the randomized pilot trial
will be enrolled and followed as part of a prospective observational cohort. Characteristics
of patients who choose CRT-P vs. CRT-D will be compared and patients' level of satisfaction
with their device decision will be measured.

Inclusion Criteria:

1. Age >/= 75 years

2. Left Ventricular Ejection Fraction (LVEF) ≤ 35% by cardiac imaging including
echocardiogram, nuclear imaging, cardiac catheterization, or cardiac magnetic
resonance imaging

3. QRS width >120 ms on surface electrocardiogram

4. New York Heart Association class II, III, or ambulatory IV for Heart Failure (HF)

5. Patient undergoing de novo CRT device implantation of CRT-D device change-out for
battery depletion

Exclusion Criteria:

1. Patient within 40 days of acute myocardial infarction

2. Patient within 3 months of cardiac revascularization (percutaneous coronary
intervention or bypass surgery)

3. Patient with prior history of cardiac arrest or documented sustained ventricular
arrhythmia

4. Patient with expected longevity < 1 year

5. Patient not on optimal medical therapy for HF management including when tolerated
β-blockers, angiotensin converting enzyme inhibitors or angiotensin receptor blockers

6. Patient not planning to have his/her follow-up at participating institution

7. Patient unable or unwilling to sign a written informed consent

8. Patient's with dementia that are unable to consent for themselves

9. Participating in any other clinical trials (observational/registries allowed)
We found this trial at
6
sites
Durham, North Carolina
Principal Investigator: Sana Al-Khatib, MD
?
mi
from
Durham, NC
Click here to add this to my saved trials
281 W. Lane Ave
Columbus, Ohio 43210
(614) 292-6446
Principal Investigator: Raul Weiss, MD
Ohio State University The Ohio State University’s main Columbus campus is one of America’s largest...
?
mi
from
Columbus, OH
Click here to add this to my saved trials
Erie, Pennsylvania 16507
Principal Investigator: Madhurmeet Singh
?
mi
from
Erie, PA
Click here to add this to my saved trials
Pittsburgh, Pennsylvania 15213
Principal Investigator: Samir Saba, MD
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Pittsburgh, Pennsylvania 15240
Principal Investigator: Alaa Shalaby
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Wormleysburg, Pennsylvania 17043
Principal Investigator: Michael Link
?
mi
from
Wormleysburg, PA
Click here to add this to my saved trials